These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19670347)

  • 1. Is maternal renal disease a cause of elevated free beta-hCG in first trimester aneuploidy screening?
    Spencer K; Enofe O; Cowans NJ; Stamatopoulou A
    Prenat Diagn; 2009 Nov; 29(11):1045-9. PubMed ID: 19670347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down syndrome maternal serum screening in patients with renal disease.
    Benachi A; Dreux S; Kaddioui-Maalej S; Czerkiewicz I; Fakhouri F; Thervet E; Muller F
    Am J Obstet Gynecol; 2010 Jul; 203(1):60.e1-4. PubMed ID: 20417486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of maternal smoking on concentrations of the pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of chorionic gonadotropin (beta hCG) in the first trimester of pregnancy].
    Gajewska J; Ceran A; Chełchowska M; Borowski D; Ambroszkiewicz J; Jaczyńska R; Zwoliński J; Laskowska-Klita T
    Przegl Lek; 2008; 65(10):479-82. PubMed ID: 19189527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome.
    Ganapathy R; Lamont RF; Bassett P
    Prenat Diagn; 2007 Nov; 27(11):995-9. PubMed ID: 17621365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester Down syndrome screening in renal-transplanted pregnant women: a model for adjusting the false-positives rates.
    Grande M; Cararach V; Casals E; Borrell A
    Prenat Diagn; 2013 May; 33(5):467-70. PubMed ID: 23505023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum free beta-hCG and PAPP-A in patients with habitual abortion-influence on first-trimester screening for chromosomal abnormalities.
    Heinig J; Steinhard J; Schmitz R; Nofer JR; Kiesel L; Klockenbusch W
    Prenat Diagn; 2007 Sep; 27(9):814-6. PubMed ID: 17554803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
    Spencer K; Crossley JA; Aitken DA; Nicolaides KH
    Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester.
    Spencer K; Liao AW; Ong CY; Geerts L; Nicolaides KH
    Prenat Diagn; 2001 Jun; 21(6):441-4. PubMed ID: 11438945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum free beta-hCG levels in uncomplicated pregnancies at the 10th-15th week of gestation and the development of obstetric complications.
    De León J; Sifuentes G; Hopkins C; Noble V; Gimpel T; Myles T; Santolaya-Forgas J
    J Reprod Med; 2004 Feb; 49(2):89-92. PubMed ID: 15018435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First trimester intact hCG as an early marker of trisomy 21: a promise unrecognised?
    Spencer K; Cowans NJ; Uldbjerg N; Vereecken A; Tørring N
    Prenat Diagn; 2008 Dec; 28(12):1156-9. PubMed ID: 19006100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.